Form 4: C4 Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Kenneth Carl Anderson, a Director of C4 Therapeutics, Inc., received 3,662 shares of common stock on October 1, 2026.
Summary
- Grant/award: acquired 3,662 Common Stock at $3.14 ($11,499) on October 1, 2026; holds 75,612 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kenneth Carl Anderson — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Grant/award | Common Stock | 3,662 | $3 | $11.5K | 75,612 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Grant/award (3,662 shares) |
Keywords
insider transaction, Form 4, CCCC, C4 Therapeutics, Inc., neutral, Kenneth Carl Anderson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.